5C50.E1ICD-11 MMS 2026-01
Cerebral organic aciduria
Description
This is a term used to classify a group of metabolic disorders which disrupt normal amino acid metabolism, particularly branched-chain amino acids, causing a buildup of acids which are usually not present.
Index terms
- Cerebral organic aciduria
- Glutaric aciduria type 1
- Glutaric acidaemia type 1
Show allHide
- Glutaryl-CoA dehydrogenase deficiency
- 2-hydroxyglutaric aciduria
- L-2-hydroxyglutaric aciduria
- D-2-hydroxyglutaric aciduria
- D-2-hydroxyglutarate dehydrogenase deficiency
- Mitochondrial isocitrate dehydrogenase deficiency
- Aminoacylase deficiency
- Neurological conditions associated with aminoacylase 1 deficiency
- Canavan disease
- Aspartoacylase deficiency
- Canavan-van Bogaert-Bertrand disease
- Spongy degeneration of central nervous system
- Malonic aciduria
- Malonyl-CoA decarboxylase deficiency
- Ethylmalonic encephalopathy
- 4-hydroxybutyric aciduria
- Gamma-hydroxybutyric acidaemia
- Succinic semialdehyde dehydrogenase deficiency
Exclusions from above levels
- http://id.who.int/icd/entity/1191191920 – Disorders of lipoprotein metabolism or certain specified lipidaemias
3A10.Z– Hereditary haemolytic anaemia due to enzyme deficiency5A71.01– Congenital adrenal hyperplasia
Show allHide
Sibling codes
Foundation entity
Cerebral organic aciduria – http://id.who.int/icd/entity/1644149132
Part of: 5C50.E: Organic aciduria › 5C50: Inborn errors of amino acid or other organic acid metabolism › 05: Endocrine, nutritional or metabolic diseases